MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1056/nejmoa1507062

Медицинская библиотека · The New England journal of medicine · 2016

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.

Heemskerk A Dorothee, Bang Nguyen D, Mai Nguyen T H, Chau Tran T H, Phu Nguyen H, Loc Pham P, Chau Nguyen V V, Hien Tran T, Dung Nguyen H, Lan Nguyen T N, Lan Nguyen H, Lan Nguyen N, Phong Le T, Vien Nguyen N, Hien Nguyen Q, Yen Nguyen T B, Ha Dang T M, Day Jeremy N, Caws Maxine, Merson Laura, Thinh Tran T V, Wolbers Marcel, Thwaites Guy E, Farrar Jeremy J

СтатьяPragmatic Clinical TrialРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Tuberculous meningitis is often lethal. Early antituberculosis treatment and adjunctive treatment with glucocorticoids improve survival, but nearly one third of patients with the condition still die. We hypothesized that intensified antituberculosis treatment would enhance the killing of intracerebral Mycobacterium tuberculosis organisms and decrease the rate of death among patients.

METHODS

We performed a randomized, double-blind, placebo-controlled trial involving human immunodeficiency virus (HIV)-infected adults and HIV-uninfected adults with a clinical diagnosis of tuberculous meningitis who were admitted to one of two Vietnamese hospitals. We compared a standard, 9-month antituberculosis regimen (which included 10 mg of rifampin per kilogram of body weight per day) with an intensified regimen that included higher-dose rifampin (15 mg per kilogram per day) and levofloxacin (20 mg per kilogram per day) for the first 8 weeks of treatment. The primary outcome was death by 9 months after randomization.

RESULTS

A total of 817 patients (349 of whom were HIV-infected) were enrolled; 409 were randomly assigned to receive the standard regimen, and 408 were assigned to receive intensified treatment. During the 9 months of follow-up, 113 patients in the intensified-treatment group and 114 patients in the standard-treatment group died (hazard ratio, 0.94; 95% confidence interval, 0.73 to 1.22; P=0.66). There was no evidence of a significant differential effect of intensified treatment in the overall population or in any of the subgroups, with the possible exception of patients infected with isoniazid-resistant M. tuberculosis. There were also no significant differences in secondary outcomes between the treatment groups. The overall number of adverse events leading to treatment interruption did not differ significantly between the treatment groups (64 events in the standard-treatment group and 95 events in the intensified-treatment group, P=0.08).

CONCLUSIONS

Intensified antituberculosis treatment was not associated with a higher rate of survival among patients with tuberculous meningitis than standard treatment. (Funded by the Wellcome Trust and the Li Ka Shing Foundation; Current Controlled Trials number, ISRCTN61649292.).

Для цитирования: Heemskerk A Dorothee, Bang Nguyen D, Mai Nguyen T H, Chau Tran T H, Phu Nguyen H, Loc Pham P, Chau Nguyen V V, Hien Tran T, Dung Nguyen H, Lan Nguyen T N, Lan Nguyen H, Lan Nguyen N, Phong Le T, Vien Nguyen N, Hien Nguyen Q, Yen Nguyen T B, Ha Dang T M, Day Jeremy N, Caws Maxine, Merson Laura, Thinh Tran T V, Wolbers Marcel, Thwaites Guy E, Farrar Jeremy J. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.. The New England journal of medicine. 2016. DOI: 10.1056/nejmoa1507062.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.